Dr Henry Beetham
Dr Henry Beetham
Details
Role
Senior Research Officer
Group
Stafford Fox Drug Discovery Facility
My expertise lies in cancer genetics, biochemistry, and high-throughput screening technologies, including high-content imaging and bioinformatics analysis. With over 10 years of research experience across prestigious institutions such as the University of Otago, the University of Edinburgh, Peter MacCallum Cancer Centre, and MCRI, I am now establishing myself as an instrumental leader in high-content imaging in Australia.
My expertise lies in cancer genetics, biochemistry, and high-throughput screening technologies, including high-content imaging and bioinformatics analysis. With over 10 years of research experience across prestigious institutions such as the...
My expertise lies in cancer genetics, biochemistry, and high-throughput screening technologies, including high-content imaging and bioinformatics analysis. With over 10 years of research experience across prestigious institutions such as the University of Otago, the University of Edinburgh, Peter MacCallum Cancer Centre, and MCRI, I am now establishing myself as an instrumental leader in high-content imaging in Australia.
Top Publications
- Beetham, H, Griffith, BGC, Murina, O, Loftus, AEP, Parry, DA, Temps, C, Culley, J, Muir, M, Unciti-Broceta, A, Sims, AH, et al. Loss of Integrin-Linked Kinase Sensitizes Breast Cancer to SRC Inhibitors.. Cancer Res 82(4) : 632 -647 2022 view publication
- Beetham, H, Chen, A, Telford, BJ, Single, A, Jarman, KE, Lackovic, K, Luxenburger, A, Guilford, P. A high-throughput screen to identify novel synthetic lethal compounds for the treatment of E-cadherin-deficient cells.. Sci Rep 9(1) : 12511 2019 view publication
- Single, A, Beetham, H, Telford, BJ, Guilford, P, Chen, A. A Comparison of Real-Time and Endpoint Cell Viability Assays for Improved Synthetic Lethal Drug Validation.. J Biomol Screen 20(10) : 1286 -1293 2015 view publication
- Chen, A, Beetham, H, Black, MA, Priya, R, Telford, BJ, Guest, J, Wiggins, GAR, Godwin, TD, Yap, AS, Guilford, PJ. E-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition.. BMC Cancer 14: 552 2014 view publication
- Carrasco, G, Stavrou, I, Treanor-Taylor, M, Beetham, H, Lee, M, Masalmeh, R, Carreras-Soldevila, A, Hardman, D, Bernabeu, MO, von Kriegsheim, A, et al. Involvement of Kindlin-1 in cutaneous squamous cell carcinoma.. Oncogenesis 13(1) : 24 2024 view publication
Page 1 of 3
Share //
